TABLE 1.

Subjects’ Demographic and Clinical Characteristics by Group Membership

Subjects’ Characteristics	Group 1 (n = 118)	Group 2 (n = 81)	P
Demographic
Age [mean (SD)]	59.03 (6.18)	59.65 (7.25)	0.52
Race [n (%)]
White	82 (69.49)	37 (46.25)	0.0008†
African American	36 (30.51)	41 (51.25)
Asian/Pacific Islander	0	1 (1.25)
American Indian/	0	1 (1.25)
Alaska Native Others	0	1 (1.25)
College education [n (%)]	65 (55.08)	45 (55.56)	0.95
Employed [n (%)]	30 (25.42)	18 (22.22)	0.60
Clinical
Years since diagnosis [median (IQR)]	14 (8–20)	13 (7.5–18)
Cirrhosis [n (%)]	47 (40.52)	17 (21.25)	0.005
Excellent/very good health status [n (%)]	36 (30.51)	20 (24.69)	0.37
Previously treated* [n (%)]	90 (76.27)	52 (64.20)	0.06
Achieved SVR [n (%)]	69 (76.67)	41 (78.85)	0.76

^*Previously received at least some treatment with pegylated interferon and ribavirin.

^†White versus nonwhite.